Syndax Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
All right. Good afternoon, everyone, thanks again for joining us at the Goldman Sachs Global Healthcare Conference. We're thrilled to have Michael Metzger; and Keith Goldan, Chief Executive and Chief Financial Officer for Syndax here with us this afternoon.
Questions & Answers
And maybe we'll just kick it off some high-level questions. First, how do you think about the core competencies of Syndax. And how does that inform kind of your strategic priorities for the business over the near term?
First of all, thank you, Corrine for inviting us here today, great opportunity to be in front of this audience. So Syndax's in a great position as a company. You mentioned our core competencies. We've been able to bring two drugs all the way through development and get them approved and certainly launched them in the last year plus has been very successful for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
